Walter Menzel
Fondatore presso Prostate Management Diagnostics, Inc.
Patrimonio netto: 12 862 $ in data 30/06/2024
Profilo
Walter B.
Menzel is the founder of Prostate Management Diagnostics, Inc., Peter Michael Foundation.
He is currently the President of WM Group.
Previously, he worked as an Independent Director at Cyanotech Corp.
and as a Senior Vice President at McCann-Erickson USA, Inc. Mr. Menzel's education includes a graduate degree in MBA from Stanford University and an undergraduate degree from the University of Wisconsin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CYANOTECH CORPORATION
0.57% | 26/06/2023 | 39 455 ( 0.57% ) | 12 862 $ | 30/06/2024 |
Posizioni attive di Walter Menzel
| Società | Posizione | Inizio |
|---|---|---|
| WM Group | Presidente | - |
Peter Michael Foundation
 Peter Michael Foundation Miscellaneous Commercial ServicesCommercial Services Peter Michael Foundation supports prostate cancer patients. It discovers and underwrites tools and technologies for the identification, treatment, and management of prostate cancer. The company was founded by Walter B. Menzel in 2004 and is headquartered in Sausalito, CA. | Fondatore | - |
Prostate Management Diagnostics, Inc.
 Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Fondatore | - |
Precedenti posizioni note di Walter Menzel
| Società | Posizione | Fine |
|---|---|---|
McCann-Erickson USA, Inc.
 McCann-Erickson USA, Inc. Advertising/Marketing ServicesCommercial Services McCann-Erickson USA, Inc. provides advertising services. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
| CYANOTECH CORPORATION | Direttore/Membro del Consiglio | - |
Formazione di Walter Menzel
| University of Wisconsin | Undergraduate Degree |
| Stanford University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CYANOTECH CORPORATION | Health Technology |
| Aziende private | 4 |
|---|---|
| WM Group | |
Peter Michael Foundation
Peter Michael Foundation Miscellaneous Commercial ServicesCommercial Services Peter Michael Foundation supports prostate cancer patients. It discovers and underwrites tools and technologies for the identification, treatment, and management of prostate cancer. The company was founded by Walter B. Menzel in 2004 and is headquartered in Sausalito, CA. | Commercial Services |
Prostate Management Diagnostics, Inc.
Prostate Management Diagnostics, Inc. BiotechnologyHealth Technology Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA. | Health Technology |
McCann-Erickson USA, Inc.
McCann-Erickson USA, Inc. Advertising/Marketing ServicesCommercial Services McCann-Erickson USA, Inc. provides advertising services. The company is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Walter Menzel
